Sartorius competitors

Charles Kummeth is a Board Member at DHR International, Board Member at BSN Medical, and Board Member at Gentherm and is based in Lake Elmo, Minnesota. He has worked as Board Member at SPARTON CORP, President/CEO at BIO-TECHNE CORP, and President Mass Spectrometry and Chromatography division at Thermo Fisher Scientific. Charles attended University of North Dakota between 1978 and 1983, Carlson School of Management between 1991 and 1993, and University of St. Thomas between 1987 and 1989.

Curt R. Hartman is the President and Chief Executive Officer of CONMED Corporation. He was appointed to the Board of Directors of CONMED on March 1, 2014, assumed the Interim CEO role on July 22, 2014, and became the full-time President and CEO on November 9, 2014. Prior to CONMED, he had a twenty-two-year career at Stryker Corporation (“Stryker”), a publicly-traded large-cap medical device company, from 1990 through February 2013. During his tenure with Stryker, he served as Interim Chief Executive Officer from February 2012 to October 2012 and as Vice President and Chief Financial Officer from April 2009 to October 2012. Mr. Hartman initially joined Stryker as a Manufacturing Engineer. He subsequently held roles of increasing responsibility to include Unit Supervisor, Production Unit Manager, Director of Information Technology, National Accounts Director and Vice President, General Manager, and Global President of the Instruments Division. Mr. Hartman has a Bachelor of Science degree in Aerospace Engineering from the University of Michigan and holds a Harvard AMP Program Certificate from Harvard Business School. He also has completed the Stryker Advanced Leadership Program at Harvard Business School. Mr. Hartman currently serves on the Board of Veran Medical Technologies, a venture-backed medical technology company.

Matthew E. Monaghan is an independent director who joined the Board in October 2016, and is a member of the Audit Committee and Nominating and Corporate Governance Committee. Mr. Monaghan currently serves as President and Chief Executive Officer at Invacare Corporation (NYSE:IVC) (“Invacare”), a medical device manufacturer for the home and long-term healthcare markets, a position he has held since April 2015. Mr. Monaghan was named Chairman of the Invacare Board in May 2015. He previously served as Senior Vice President, Global Hips and Reconstructive Research for Zimmer Biomet Holdings, Inc. (formerly known as Zimmer Holdings, Inc.) (“Zimmer”), a global company that designs, develops, manufactures and markets orthopedic reconstructive, spinal and trauma devices, dental implants, and related surgical products from 2014 to 2015. Mr. Monaghan also has served as Operating Executive for Texas Pacific Group from 2006 to 2009 and at Cerberus Capital Management from 2003 to 2005. He started his career with 13 years in the aerospace, medical and other industrial businesses of General Electric. Mr. Monaghan is a trustee of Cleveland Clinic Avon Lake Hospital. Mr. Monaghan was a member of the board of directors of CD Diagnostics, Inc. from 2012 to 2016 and served as the chairman of the Audit Committee from 2012 to 2015 and as chairman of the board from 2015 to 2016. He holds a Bachelor’s degree in Mechanical Engineering from Cornell University, a Master’s degree in Mechanical Engineering from MIT and an MBA from INSEAD Business School in France.

David J. Endicott is the CEO of Alcon, a member of its Board of Directors, and leads the Alcon Executive Committee. He joined Alcon in July of 2016 as Chief Operating Officer. Prior to Alcon, Mr. Endicott was President of Hospira Infusion Systems, a Pfizer company. During his tenure there, he led Hospira’s medical device business through a turnaround, carve-out, and eventual sale. Critical to the turnaround, he advanced the company’s product pipeline, returned its products to market from quality disruptions and accelerated global growth. Before joining Hospira, David served as an officer and executive committee member of Allergan where he spent more than 25 years of his career in leadership roles across Europe, Asia, Latin America and the US. He accelerated Allergan’s international growth and successfully built new markets focused on medical specialties in the areas of ophthalmology, plastic surgery, dermatology and aesthetic medicine. He currently serves on the Board of Directors of AdvaMed, and has previously served on the Boards of Zeltiq (NASDAQ: ZLTQ), and Orexigen (NASDAQ: OREX). David holds an undergraduate degree in Chemistry from Whitman College, an MBA from the University of Southern California, and is a graduate of the Advanced Management Program at the Harvard Business School.

Jean-Claude Dubacher is Chairman and CEO of B. Braun of America Inc., which includes B. Braun Medical Inc., B. Braun Interventional Systems, Aesculap® and CAPS®. Mr. Dubacher joined B. Braun in August 2019 as President, B. Braun Medical Inc., and has served as Chairman and Chief Executive Officer of B. Braun Medical Inc. since January 1, 2020. Dubacher’s experience in healthcare spans more than 15 years in consulting and corporate roles including strategy, commercial, supply chain and manufacturing. Prior to joining B. Braun, Dubacher led commercial operations for the Surgical Ophthalmology Division of Johnson & Johnson (formerly Abbott Medical Optics) in Europe. Throughout his career, Mr. Dubacher has demonstrated a passion for focusing on customer needs and supporting people to be successful in developing, manufacturing, marketing, and selling products and services that benefit patients. Dubacher holds a Doctorate Degree in law (Dr. iur.) from the University of Zurich in Switzerland, and an MBA from Harvard Business School. He is a board member for the German American Chamber of Commerce.

Carlo Rosa is a CEO/General Manager at Diasorin, Board Member at Diasorin, and Chief Executive Officer at Diasorin GmbH. He has worked as Chief Operating Officer at Diasorin. Carlo works or has worked at Incstar Corp and works or has worked as Partner at Bioinvestment SA, Board Member at Sarago Srl, and Partner at Cid Investments Srl. He attended Unito.

Scott Meuser is a Chairman and Chief Executive Officer at Pride Mobility Products Corp and is based in United States. She works or has worked at Pride Mobility Products Corp.